Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib". Jiang Y, Zhang L. J Thorac Oncol 2024;19:e43.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang Y, Zhang L. Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib". J Thorac Oncol 2024;19:e43.
PMID: 39242149